BOSTON, Massachusetts and BERGISCH GLADBACH, Germany, May 4, 2010 /PRNewswire/ -- Stemgent, Inc., and Miltenyi Biotec today announced a strategic collaboration for co-development and commercialization ...

SAN FRANCISCO--(BUSINESS WIRE)--MiLaboratories, a leader in RNA immune technologies, and Miltenyi Biotec, a global pioneer in biotechnology, are excited to announce a landmark partnership that ...

SANTA BARBARA, Calif. & BERGISCH GLADBACH, Germany--(BUSINESS WIRE)--Miltenyi Biotec announced today that it has completed acquisition of Owl biomedical, Inc., an emerging company developing and ...

PHILADELPHIA, Sept. 25, 2025 /PRNewswire/ -- Verismo Therapeutics, a clinical-stage CAR T company developing a novel KIR-CAR platform technology, today announced the successful manufacture of its ...

NEW YORK, Dec. 29, 2023 (GLOBE NEWSWIRE) -- Cell BioEngines, Inc., a clinical-stage biotechnology company focused on delivering novel, innovative stem cell and immune cell therapies to address blood ...

(RTTNews) - Bio-Techne Corp. (TECH), a life sciences company, announced Tuesday that it has won a second claim of reverse engineering by Miltenyi Biotec B.V. & Co. KG, which may appeal the Court's ...

The workflow eliminates the need for strict RNase-free environments and enables simple and robust whole-brain 3D imaging of transcriptional signatures, cell identity markers and noncoding RNAs at ...

Bio-Techne (TECH) prevailed on another claim that Miltenyi Biotec KG commercialized antibodies developed based on information obtained by reverse engineering Bio-Techne’s proprietary R&D Systems ...

Biomedical and clinical research company Miltenyi Biotec says that it has fully restored systems after a malware attack that took place last month and affected the firm's global IT infrastructure.

Miltenyi Biotec announced that it has completed acquisition of Owl biomedical, Inc., an emerging company developing and commercializing microchip-based cell sorting systems using fully-closed ...